Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is the Incidence of Early Antibody Formation after Resuscitation of Hemorrhage? A Comparison of RH(D)+ Whole Blood and RH(D)- Red Blood Cells in 3,531 Trauma Patients.

Annals of surgery·2026
Same author

An in vivo assessment of green plasma: The potential hemostatic superiority of a currently discarded blood product.

The journal of trauma and acute care surgery·2026
Same author

Executing balanced resuscitation in bleeding combat casualties: Good versus good enough?

The journal of trauma and acute care surgery·2026
Same author

Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage.

The New England journal of medicine·2026
Same author

When does 1:1 resuscitation really matter? An analysis of 4,858 patients from four traumatic hemorrhage studies.

The journal of trauma and acute care surgery·2026
Same author

Tracheostomy Placement in Patients with High Ventilator Settings: Study of 1,694 Tracheostomies.

Journal of the American College of Surgeons·2026

Related Experiment Video

Updated: Jun 20, 2026

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
07:51

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs

Published on: May 21, 2019

Transfusion therapy in hemorrhagic shock.

Timothy C Nunez1, Bryan A Cotton

  • 1Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, USA.

Current Opinion in Critical Care
|September 5, 2009
PubMed
Summary

Early blood product transfusion, including plasma and platelets with red blood cells, improves survival in trauma patients with acute coagulopathy. This damage control resuscitation strategy is crucial for exsanguinating patients.

More Related Videos

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
08:14

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Published on: March 22, 2024

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Related Experiment Videos

Last Updated: Jun 20, 2026

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
07:51

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs

Published on: May 21, 2019

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
08:14

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Published on: March 22, 2024

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Area of Science:

  • Trauma critical care
  • Hemorrhagic shock management
  • Massive transfusion protocols

Background:

  • Hemorrhage is a leading cause of death in trauma patients.
  • Resuscitation strategies have evolved, influenced by military experience.
  • Acute coagulopathy of trauma affects a significant percentage of patients.

Purpose of the Study:

  • To review the damage control resuscitation strategy.
  • To focus on early and frequent transfusion of blood products (red cells, plasma, platelets).
  • To discuss the optimal ratios of blood products in massive transfusion.

Main Methods:

  • Review of available data and retrospective studies.
  • Analysis of outcomes in trauma patients receiving early blood product transfusion.
  • No randomized controlled trials currently exist comparing damage control hematology to traditional methods.

Main Results:

  • Overwhelming data supports high ratios of plasma and platelets to packed red blood cells.
  • Retrospective studies suggest ratios near 1:1 improve survival.
  • Early identification of coagulopathy and initiation of damage control hematology are linked to better outcomes.

Conclusions:

  • Acute coagulopathy of trauma is prevalent.
  • Early damage control hematology improves outcomes for massive transfusion patients.
  • Data suggests a plasma-to-packed red blood cell ratio greater than 2:3 is beneficial.